<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03340246</url>
  </required_header>
  <id_info>
    <org_study_id>DELICATVE</org_study_id>
    <nct_id>NCT03340246</nct_id>
  </id_info>
  <brief_title>Delayed or Immediate Local Treatment of Veins</brief_title>
  <acronym>DELICATVE</acronym>
  <official_title>Delayed or Immediate Local Treatment of Varicose Veins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Varicose veins affect a majority of adult patients and cause a decreased quality of life. In&#xD;
      recent years, standard practice has been to perform thermoablation and local phlebectomies in&#xD;
      the same procedure. There is conflicting data on the long-term outcome of the local varicose&#xD;
      veins; there seems to be a need for more re-interventions if the local varicosities are not&#xD;
      treated immediately. On the other hand, the prolonged combined procedure increases procedural&#xD;
      pain and bleeding, as well as the risk for complications from deep vein thrombosis/pulmonary&#xD;
      embolism.&#xD;
&#xD;
      This trial aims to evaluate the need for immediate treatment of local varicosities and the&#xD;
      potential sufficiency of main trunk treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 4, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Actual">December 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Need for sclerotherapy</measure>
    <time_frame>3 months</time_frame>
    <description>Need for sclerotherapy of varicosities at three months after ablation of main trunk. Evaluated by the CEAP-classification of venous insufficiency. &gt;C2 will be eligible for treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>3 months</time_frame>
    <description>Overall patient satisfaction and symptoms regarding varicosities and procedure at three months. Evaluated by the Aberdeen Varicose Veins Questionnaire (AVVQ). The AVVQ is a validated test, in which patients are asked to check boxes with regard to symptoms and quality of life (QoL). Scale 0-100, with 100 indicating worst possible QoL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occlusion rate of great saphenous vein</measure>
    <time_frame>36 months</time_frame>
    <description>Long-term occlusion rate of main trunk after mechanochemical ablation, evaluated by duplex ultrasound.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Varicose Veins Leg</condition>
  <arm_group>
    <arm_group_label>Immediate phlebectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mechanochemical ablation of main trunk and immediate phlebectomy of varicosities</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mechanochemical ablation of main trunk. Evaluation of varicosities at 3 months with sclerotherapy if required</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Delayed sclerotherapy</intervention_name>
    <description>See arm descriptions</description>
    <arm_group_label>Delayed treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Immediate phlebectomy</intervention_name>
    <description>See arm description</description>
    <arm_group_label>Immediate phlebectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ultrasound verified insufficiency of great saphenous vein (GSV)&#xD;
&#xD;
          -  GSV diameter 5-10 mm&#xD;
&#xD;
          -  C2-C4 varicosities&#xD;
&#xD;
          -  Most proximal insufficient branch in the distal thigh&#xD;
&#xD;
          -  Written and signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Peripheral arterial disease&#xD;
&#xD;
          -  Body mass index &gt;40&#xD;
&#xD;
          -  Lymphoedema&#xD;
&#xD;
          -  Known allergy to sclerosant&#xD;
&#xD;
          -  Any known coagulopathy or history of deep vein thrombosis&#xD;
&#xD;
          -  Severe illness&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karoliina Halmesm√§ki, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maarit Venermo, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>October 13, 2017</study_first_submitted>
  <study_first_submitted_qc>November 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Maarit Venermo</investigator_full_name>
    <investigator_title>Professor of Vascular Surgery</investigator_title>
  </responsible_party>
  <keyword>Varicose veins, phlebectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

